反相蛋白微阵列实现胶质母细胞瘤分子亚型分型
研究用反相蛋白微阵列(RPPA)检测胶质母细胞瘤中12条重要信号通路的磷酸化状态,分析60余例肿瘤及对照活检组织,识别出基于pCREB1/CREB1、NOTCH-ICD/NOTCH1和pGSK3β/GSK3β比值的三种激活模式,与总生存相关,高pGSK3β/GSK3β比值与较差生存相关。
要点
- RPPA可基于pCREB1/CREB1、NOTCH-ICD/NOTCH1和pGSK3β/GSK3β比值将胶质母细胞瘤分为三种激活模式。
- 高pGSK3β/GSK3β比值与较差总生存相关。
- CREB1、NOTCH1、GSK3β磷酸化状态与胶质瘤分级相关。
核心结论
- RPPA是一种快速可靠的工具,可在个体肿瘤中补充形态学诊断的通路特异性信息。
- 这些数据可用于分子分型和可能的联合治疗规划。
- 结果可能优化当前的胶质瘤分级算法。
研究设计与样本
- 研究对来自肿瘤中心和周边(基于神经导航)的60余例肿瘤和对照活检组织采用反相蛋白微阵列(RPPA)进行选择性蛋白表达分析,所用抗体针对翻译后修饰的癌症通路蛋白。
- 评估磷酸化(或修饰)与非磷酸化蛋白的比值,所有样本经组织病理学验证,蛋白组学特征与临床和生存数据相关。
主要发现
- 通过RPPA识别出胶质母细胞瘤内三种不同的激活模式,分别由pCREB1/CREB1、NOTCH-ICD/NOTCH1和pGSK3β/GSK3β的比值定义。
- 这些亚类在单机构患者队列和公开数据分析中显示出不同的总生存模式。
- 高pGSK3β/GSK3β比值与较差生存相关。
- 在U373和U251细胞系中,Wnt激活/GSK3β抑制可阻止胶质瘤细胞增殖和迁移。
- 来自多个活检的蛋白组学特征不同的患者总生存更差。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the present study we investigated the phosphorylation status of the 12 most important signaling cascades in glioblastomas. More than 60 tumor and control biopsies from tumor center and periphery (based on neuronavigation) were subjected to selective protein expression analysis using reverse-phase protein arrays (RPPA) incubated with antibodies against posttranslationally modified cancer pathway proteins. The ratio between phosphorylated (or modified) and non-phosphorylated protein was assessed. All samples were histopathologically validated and proteomic profiles correlated with clinical and survival data. By RPPA, we identified three distinct activation patterns within glioblastoma defined by the ratios of pCREB1/CREB1, NOTCH-ICD/NOTCH1, and pGSK3β/GSK3β, respectively. These subclasses demonstrated distinct overall survival patterns in a cohort of patients from a single-institution and in an analysis of publicly available data. In particular, a high pGSK3β/GSK3β-ratio was associated with a poor survival. Wnt-activation/GSK3β-inhibition in U373 and U251 cell lines halted glioma cell proliferation and migration. Gene expression analysis was used as an internal quality control of baseline proteomic data. The protein expression and phosphorylation had a higher resolution, resulting in a better class-subdivision than mRNA based stratification data. Patients with different proteomic profiles from multiple biopsies showed a worse overall survival. The CREB1-, NOTCH1-, GSK3β-phosphorylation status correlated with glioma grades. RPPA represent a fast and reliable tool to supplement morphological diagnosis with pathway-specific information in individual tumors. These data can be exploited for molecular stratification and possible combinatorial treatment planning. Further, our results may optimize current glioma grading algorithms.
引用
- Hutter G, Sailer M, Azad TD, et al. Reverse phase protein arrays enable glioblastoma molecular subtyping. J Neurooncol. 2016. PMID: 27858266. doi:10.1007/s11060-016-2316-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。